Late Effects in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia.

This large population-based analysis is among the first to describe late effects in survivors of AYA ALL. The strong association between insurance type and late effects suggests that AYAs with public or no insurance may have reduced access to survivorship care following completion of ALL therapy.